Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas) [Phase 3]

View source ↗

Summary

Phase 3 trial of SBRT in newly diagnosed stage IV EGFR-mutated non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Egfr-mutated Non-small Cell Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Stage IV EGFR Mutated Non-Small Cell Lung Cancer | Phase 3 | Status: TERMINATED